In the last trading session, 1.18 million Nutex Health Inc (NASDAQ:NUTX) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $0.23 changed hands at $0.0 or -0.73% during last session, the market valuation stood at $155.15M. NUTX’s last price was a discount, traded about -969.57% off its 52-week high of $2.46. The share price had its 52-week low at $0.18, which suggests the last value was 21.74% up since then. When we look at Nutex Health Inc’s average trading volume, we note the 10-day average is 0.87 million shares, with the 3-month average coming to 1.67 million.
Analysts gave the Nutex Health Inc (NUTX) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NUTX as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Nutex Health Inc’s EPS for the current quarter is expected to be $0.
Nutex Health Inc (NASDAQ:NUTX) trade information
Instantly NUTX was in red as seen at the end of in last trading. With action -3.62%, the performance over the past five days has been red. The drop to weekly highs of 0.2660 on Friday, 11/17/23 subtracted -0.73% to the stock’s daily price. The company’s shares are showing year-to-date downside of -87.83%, with the 5-day performance at -3.62% in the red. However, in the 30-day time frame, Nutex Health Inc (NASDAQ:NUTX) is 13.72% up. Looking at the short shares, we see there were 2.18 million shares sold at short interest cover period of 2.42 days.
The consensus price target for the stock as assigned by Wall Street analysts is $1.88, meaning bulls need an upside of 87.77% from its current market value. According to analyst projections, NUTX’s forecast low is $1.50 with $2.25 as the target high. To hit the forecast high, the stock’s price needs a -878.26% plunge from its current level, while the stock would need to soar -552.17% for it to hit the projected low.
Nutex Health Inc (NUTX) estimates and forecasts
Data shows that the Nutex Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -58.44% over the past 6 months, a 25.00% in annual growth rate that is considerably higher than the industry average of 5.70%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Nutex Health Inc will rise 100.00%, while the growth in revenue is estimated to hit 100.00% for the next quarter. Year-over-year growth is forecast to reach 11.70% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of $66.86 million. 1 analysts are of the opinion that Nutex Health Inc’s revenue for the quarter ending Mar 2024 will be $72.6 million. The company’s revenue for the corresponding quarters a year ago was $53.72 million. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 24.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 55.01%. The 2023 estimates are for Nutex Health Inc earnings to increase by 96.27%.
Nutex Health Inc is expected to release its next quarterly earnings report on November 09.
Nutex Health Inc (NASDAQ:NUTX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 49.52% of Nutex Health Inc shares while 6.35% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.57%. There are 6.35% institutions holding the Nutex Health Inc stock share, with Vanguard Group Inc the top institutional holder. As of Jun 29, 2023, the company held 1.47% of the shares, roughly 9.72 million NUTX shares worth $4.1 million.
Truist Financial Corp holds the second largest percentage of outstanding shares, with 0.52% or 3.45 million shares worth $1.45 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and Vanguard Russell 2000 Index Fund. With 9.06 million shares estimated at $3.82 million under it, the former controlled 1.37% of total outstanding shares. On the other hand, Vanguard Russell 2000 Index Fund held about 0.10% of the shares, roughly 0.67 million shares worth around $0.29 million.